Therapeutics and diagnostic company focused on pandemic diseases. |
|
Therapeutics and diagnostic company focused on pandemic diseases. |
|
https://www.shuttlepharma.com/
Shuttle Pharmaceuticals develops radiation sensitizing drugs to improve the outcomes of patients undergoing radiation therapy for cancer treatment. Clinical phase drug candidates include ropidoxuridine for sensitizing rapidly growing tumors and doranidazole for sensitizing hypoxic cancers that are resistant to radiation therapy. |
|
Seraxis, a private biotech company, is developing a cell therapy to cure insulin-dependent diabetes by replacing the beta cells of the pancreas. Their team of scientists created an induced Pluripotent Stem Cell (iPSC) line, that differentiates robustly into insulin-producing pancreatic cells. These cells are encapsulated to protect them from immune attacks and implanted in relevant models of type-1-diabetes. The safety and efficacy of the Seraxis therapy, SR-01, has been assessed in mice, rat and non-human primates in pre-clinical studies. The well-characterized and stable insulin-producing cells demonstrated a high level of purity, response to glucose challenge and secreted insulin over the 6 months of the studies. Additionally, Seraxis encapsulation technology was shown to efficiently protect these cells from the host immune destruction, while allowing vascularization and nutrition of the cells. In an on-going study, SR-01 has been shown to restore normal glycemic control in immune-competent diabetic rats for more than 3 months. |
|
Neuralstem's patented technology enables the commercial-scale production of multiple types of central nervous system stem cells, which are under development for the potential treatment of central nervous system diseases and conditions. |
|
Therapeutics for neurodegenerative diseases including for Parkinson's and Alzheimer's. |
|
Developing innovation therapeutic monoclonal antibody drugs. |
|
Building customized electronic health records for radiation oncology practices. |
|
Business development for Health IT. |
|
Intelligent Fusion Technology (IFT) specializes in the development and implementation of Data Fusion Technologies. IFT extracts the maximum amount of information from many data sources, to provide more accurate situational awareness than any individual data source could offer. IFT aggressively promotes the insertion of our revolutionary technologies into the marketplace by producing hardware and software for the Defense, Commercial, and Industrial sectors. Comprised of scientifically creative engineers with the rare ability to combine theoretical research and hardware implementation IFT develops products to for a wide range of complex needs. |
|
HR consulting practice focused on healthcare professionals. |
|
Developing a proprietary technology for isolating and using adult stem cells for treatment of osteoarthritis and rheumatoid arthritis |
Akan Biosciences
|
NuSep is a Life Sciences company that provides innovative tools that speed up and simplify protein separation, fractionation, and proteomic analysis. We also developing a novel clinical diagnostic platform to improve health outcomes. |
BiOneCure Therapeutics LLC is a biotechnology company committed to the discovery and development of innovative biotherapeutics for the treatment of cancer. The company is developing novel bispecific antibodies and a new class of antibody-drug conjugates (ADCs). Bispecific antibodies combine specificities of two different antibodies and are able to target two different antigens or epitopes simultaneously. ADCs are tumor-targeting antibodies chemically conjugated to a highly potent cytotoxic agent (warheads). Bispecific antibodies and ADCs promise huge potential for cancer therapy. A series of novel cytotoxic warheads being developed by BiOneCure feature new mechanisms of action for tumor cell killing and inhibition, which will enhance the therapeutic application and the safety of ADCs in clinical treatment of cancer patients. The company was founded in 2016 by industrial veterans and is based in Germantown, Maryland. |
Theraly is a preclinical stage company that applies a novel, proprietary technology platform to create new drugs and improve existing drugs. Theraly aims to preserve the potency of peptides and small proteins while increasing their circulating half-lives. |
AcouSort is a Swedish company setting up a US presence. The company has a novel technology that uses acoustic fields to separate cells and particles to perform operations that is normally done by centrifugation in the biology or clinical lab. |
The Fusion of Technology and Genomics. |
http://www.epigenomics.com/en/
Epigenomics is a molecular diagnostics company focused on developing innovative screening tests for cancer. Our lead product, Epi proColon, is the first and only FDA-approved blood-based test for colorectal cancer. In the US today, 1 in 3, or 23 million eligible people, are not screened for colorectal cancer. Epi proColon provides a convenient blood-based option to address this non-screened population. |
|
CLIA approved diagnostic test for detection of pancreatic cancer to inform chemotherapy regimen. |
Adera Labs
|
3I was founded in 2013 to develop a cost-effective, accurate, and easy-to-use diagnostic that would improve the effectiveness of antibiotics-related clinical decisions. |
|
Immuno-oncology company developing CAR T-Cell Therapy for treatment of Cancer. |
|
Developing botulinum toxin and other neurotoxin productions. US Office for Medytox Inc. |
|